Valuation: Biogen Inc.

Market Cap 29.62B 26.05B 24.2B 22.26B 41.74B 2,868B 42.49B 289B 113B 1,399B 111B 109B 4,854B P/E 2026 *
24.4x
P/E 2027 * 16x
Enterprise Value 34.93B 30.72B 28.54B 26.25B 49.23B 3,383B 50.11B 341B 133B 1,650B 131B 128B 5,725B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.18x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+1.46%
1 week-3.97%
Current month-7.15%
1 month+1.74%
3 months+6.78%
6 months+16.92%
Current year+14.00%
1 week 196.92
Extreme 196.915
205.65
1 month 186.02
Extreme 186.025
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 124.56
Extreme 124.5561
219.72
3 years 110.04
Extreme 110.035
280.42
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 2022-11-13
Director of Finance/CFO 60 2025-02-28
Chief Tech/Sci/R&D Officer - 2020-12-31
Director TitleAgeSince
Director/Board Member 69 2010-03-22
Director/Board Member 77 2009-12-31
Director/Board Member 72 2019-06-18
Date Insider Type Main position Quantity % Market Cap.
6/9/26 Free

Director

1,505 0.0010%
6/9/26 Free

Director

1,505 0.0010%
6/9/26 Free

Chairman

2,005 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%-3.97%+53.17%-27.51% 29.19B
+0.11%-3.98%+13.89%-11.26% 66.25B
-0.12%+2.23%+36.63%+196.27% 52.86B
+0.51%+37.90%+37.90%+37.90% 43.01B
-1.15%-7.15%-57.52%-57.00% 39.52B
+0.78%+0.03%+65.07%+81.90% 23.13B
-1.81%-9.71%+64.46%-54.90% 23.04B
-1.30%-3.34%+3.47%+177.59% 20.48B
-1.04%-1.59%+66.57%+119.96% 16.6B
+0.33%+3.28%+79.54%+142.98% 16.2B
Average -0.22%-2.25%+36.32%+60.59% 33.03B
Weighted average by Cap. -0.12%-2.19%+27.92%+50.80%

Financials

2026 *2027 *
Net sales 10.07B 8.86B 8.23B 7.57B 14.19B 975B 14.44B 98.37B 38.37B 476B 37.8B 36.98B 1,650B 10.32B 9.07B 8.43B 7.75B 14.54B 999B 14.8B 101B 39.32B 487B 38.73B 37.9B 1,691B
Net income 1.29B 1.13B 1.05B 969M 1.82B 125B 1.85B 12.59B 4.91B 60.89B 4.84B 4.73B 211B 1.99B 1.75B 1.62B 1.49B 2.8B 192B 2.85B 19.41B 7.57B 93.83B 7.46B 7.3B 326B
Net Debt 5.32B 4.67B 4.34B 3.99B 7.49B 515B 7.62B 51.93B 20.26B 251B 19.96B 19.52B 871B 3.23B 2.84B 2.64B 2.43B 4.55B 313B 4.63B 31.53B 12.3B 152B 12.12B 11.85B 529B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
26-07-23 US$200.62 +1.46% 1,032,068
26-07-22 US$197.74 -2.67% 841,350
26-07-21 US$203.16 +1.61% 652,841
26-07-20 US$199.95 -2.93% 963,088
26-07-17 US$205.99 -1.40% 1,151,283
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
200.54USD
Average target price
227.59USD
Spread / Average Target
+13.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock